Multidisciplinary teams for cardiogenic shock

hypoperfusion due to a primary cardiac problem associated with high mortality and morbidity in the contemporary era [1, 2]. More than 80% of all CS cases in the modern era are due to acute myocardial infarction (AMI) [1, 2]. Despite rapid advancements in the field of interventional cardiology and percutaneous coronary interventions (PCI), AMI-CS continues to be associated with high mortality in excess of 30-40% [3-5]. However, despite shorter door-to-balloon times and greater use of coronary angiography and PCI in recent years, there appears to be minimal incremental mortality benefit in this population [1]. AMI-CS follows a ‘hemometabolic’ cascade, wherein the initial hemodynamic Editorial